An exploratory, non-interventional study to biotype patients with facioscapulohumeral muscular dystrophy (FSHD) and controls using digital technologies

Completed

• Conditions: FSHD; Facioscapulohumeral dystrophy; 10028396; 10028302

• Registration Number: NL-OMON48191
• Lead Sponsor: Facio Therapies

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 2020-11-02
• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

* FSHD patients:
Genetically confirmed FSHD.
Symptomatic, as demonstrated by Lamperti score >0.
Android-based smartphone with Android version 5.0 or higher.
Age 16+ years.;* Controls:
Unrelated subjects without FSHD.
Android-based smartphone with Android version 5.0 or higher.
Age 16+ years.

Exclusion Criteria

* FSHD patients:
Inability to give consent.
Current or previously diagnosed illness or any clinical condition that, in the opinion of the investigator, might confound the results of the study.;* Controls:
Inability to give consent.
Current or previously diagnosed illness or any clinical condition that, in the opinion of the investigator, might confound the results of the study.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified